Workflow
HSJN(002817)
icon
Search documents
黄山胶囊跌2.01%,成交额598.38万元
Xin Lang Cai Jing· 2025-09-23 01:55
Company Overview - Huangshan Capsule Co., Ltd. is located in Anhui Province and was established on August 12, 1996, with its listing date on October 25, 2016 [2] - The company specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules [2] - The revenue composition includes gelatin hollow capsules (64.54%), enteric-coated gelatin hollow capsules (19.22%), and plant capsules and others (16.24%) [2] Stock Performance - As of September 23, the stock price of Huangshan Capsule decreased by 2.01% to 7.32 CNY per share, with a total market capitalization of 2.189 billion CNY [1] - Year-to-date, the stock price has increased by 18.16%, but it has seen a decline of 5.91% over the last five trading days, 9.85% over the last 20 days, and 1.88% over the last 60 days [2] Financial Performance - For the period from January to June 2025, Huangshan Capsule achieved a revenue of 244 million CNY, representing a year-on-year growth of 3.66% [2] - The net profit attributable to the parent company was 35.55 million CNY, showing a year-on-year increase of 19.78% [2] Shareholder Information - As of June 30, 2025, the number of shareholders was 17,900, a decrease of 2.57% from the previous period [2] - The average circulating shares per person increased by 2.64% to 16,197 shares [2] - The company has distributed a total of 125 million CNY in dividends since its A-share listing, with 62.81 million CNY distributed over the last three years [3] Institutional Holdings - As of June 30, 2025, among the top ten circulating shareholders, Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund (004685) held 1.6367 million shares, an increase of 129,400 shares from the previous period [3] - Nu'an Multi-Strategy Mixed A Fund (320016) entered as a new shareholder, holding 1.3943 million shares [3]
国有企业视角下的儒商精神与工商业文明实践
Qi Lu Wan Bao· 2025-09-19 11:22
Core Viewpoint - State-owned enterprises (SOEs) play a crucial role in China's economic and social development, serving as a significant foundation for socialism with Chinese characteristics and a vital support for the ruling party [1][2]. Group 1: Achievements of State-Owned Enterprises - Since the founding of New China, especially after the reform and opening up, SOEs have made historic contributions to economic development, technological progress, social construction, national defense, and improving people's livelihoods [1]. - The Jining Energy Development Group, under the leadership of Zhang Guangyu, has successfully transformed from a coal-dependent enterprise to a comprehensive energy group, achieving a revenue of over 90 billion yuan in 2024 and ranking 18th among China's logistics companies [6][4]. Group 2: Entrepreneurial Spirit and Cultural Influence - The entrepreneurial spirit is essential for the growth of SOEs, and the leaders of these enterprises embody this spirit, which is deeply influenced by Confucian culture [2][3]. - The city of Jining, as a significant birthplace of Confucian thought, fosters a unique entrepreneurial charm among its business leaders, who are recognized as modern Confucian merchants [2]. Group 3: Infrastructure and Urban Development - The construction of the Jining Inner Ring Expressway, led by Li Lu, has significantly improved urban traffic flow, with a daily traffic volume of 180,000 vehicles, enhancing the city's infrastructure and connectivity [7][9]. - The Jining Public Utilities Company has transformed from a traditional water supply enterprise into a comprehensive urban service provider with assets totaling 76.848 billion yuan, contributing to urban construction and public services [6][8]. Group 4: Social Responsibility and Community Development - The "Mujie" project, initiated by the Jining State-owned Assets Investment Holding Company, has revitalized a former grain depot into a vibrant commercial area, enhancing the local economy and community life [10][11]. - The establishment of the first state-owned childcare group in Shandong Province demonstrates the commitment of Jining National Investment to social responsibility, providing quality care for infants and toddlers [11][12]. Group 5: Innovation and Technological Advancement - The Shandong Lutai Holding Group, under the leadership of Li Hejun, has focused on technological innovation, establishing a graphene research center and achieving significant breakthroughs in high-performance materials [13][14]. - The company's strategic acquisitions and emphasis on research and development have positioned it among the top 50 coal producers in China, showcasing its commitment to modernizing and diversifying its operations [14].
黄山胶囊2025年中报简析:营收净利润同比双双增长,盈利能力上升
Zheng Quan Zhi Xing· 2025-08-23 23:29
Core Viewpoint - Huangshan Capsule (002817) reported a positive financial performance for the first half of 2025, with increases in revenue and net profit compared to the previous year [1] Financial Performance Summary - Total revenue for the first half of 2025 reached 244 million yuan, a year-on-year increase of 3.66% [1] - Net profit attributable to shareholders was 35.55 million yuan, reflecting a year-on-year growth of 19.78% [1] - In Q2 2025, total revenue was 125 million yuan, up 6.83% year-on-year, while net profit was 16.72 million yuan, an increase of 16.44% [1] - Gross margin improved to 28.98%, with a year-on-year increase of 13.62%, and net margin rose to 14.68%, up 15.51% [1] Key Financial Metrics - Operating expenses (sales, management, and financial expenses) totaled 22.48 million yuan, accounting for 9.22% of revenue, which is a 10.63% increase year-on-year [1] - Earnings per share (EPS) increased to 0.12 yuan, a growth of 20.00% compared to the previous year [1] - Cash flow from operating activities per share reached 0.1 yuan, a significant increase of 355.3% year-on-year [1] Changes in Financial Items - Income tax expenses increased by 35.36% due to a rise in total profit [3] - Net cash flow from operating activities surged by 355.3%, attributed to increased cash received from sales and reduced cash payments related to operating activities [3] - Net cash flow from investing activities rose by 47.61%, due to increased cash received from investment-related activities [3] Business Evaluation - The company's return on invested capital (ROIC) was 4.15%, indicating a relatively weak capital return [3] - Historical data shows a median ROIC of 6.71% since the company went public, with the lowest ROIC recorded in 2018 at 3.96% [3] - The company's cash assets are reported to be very healthy, indicating strong solvency [3] Accounts Receivable Situation - The accounts receivable to profit ratio has reached 272.93%, suggesting a need for attention in this area [3]
安徽黄山胶囊股份有限公司2025年半年度报告摘要
Core Viewpoint - The company, Anhui Huangshan Capsule Co., Ltd., has released its 2025 semi-annual report, which reflects its financial status and operational results for the first half of the year [1][10]. Group 1: Company Overview - The company is identified by the securities code 002817 and is referred to as Huangshan Capsule [1]. - The legal representative of the company is Li Hejun [8]. Group 2: Board Meeting - All directors attended the board meeting that reviewed the semi-annual report [2]. - The board meeting was held on August 22, 2025, with all seven directors present, including one participating via remote voting [9]. - The board approved the 2025 semi-annual report and its summary, which will be disclosed through designated media [10][16]. Group 3: Audit and Compliance - The board and the supervisory committee confirmed that the semi-annual report was prepared and reviewed in compliance with legal and regulatory requirements, ensuring the content is true, accurate, and complete [16][18]. - There were no non-standard audit opinions or changes in the controlling shareholder during the reporting period [3][5][6].
黄山胶囊:第五届董事会第十三次会议决议公告
Zheng Quan Ri Bao· 2025-08-22 16:07
Core Viewpoint - Huangshan Capsule announced the approval of its 2025 semi-annual report and summary by the company's fifth board of directors at its thirteenth meeting [2] Company Summary - The announcement was made on the evening of August 22 [2]
黄山胶囊:第五届监事会第十三次会议决议公告
Zheng Quan Ri Bao· 2025-08-22 16:07
Core Viewpoint - Huangshan Capsule announced the approval of its 2025 semi-annual report and summary by the 13th meeting of the fifth supervisory board [2] Group 1 - The company held a meeting to review and approve the semi-annual report [2]
黄山胶囊:2025年半年度归属于上市公司股东的净利润同比增长19.78%
Zheng Quan Ri Bao· 2025-08-22 16:06
Core Viewpoint - Huangshan Capsule reported a revenue of 243,881,502.87 yuan for the first half of 2025, reflecting a year-on-year growth of 3.66% [2] - The net profit attributable to shareholders of the listed company was 35,552,521.32 yuan, showing a year-on-year increase of 19.78% [2] Financial Performance - The company's revenue for the first half of 2025 reached approximately 243.88 million yuan, marking a growth of 3.66% compared to the previous year [2] - The net profit for the same period was around 35.55 million yuan, which is a significant increase of 19.78% year-on-year [2]
黄山胶囊:上半年净利润3555.25万元 同比增长19.78%
Core Insights - The company reported a revenue of 244 million yuan for the first half of 2025, representing a year-on-year growth of 3.66% [1] - The net profit attributable to the parent company reached 35.55 million yuan, showing a year-on-year increase of 19.78% [1] - The basic earnings per share stood at 0.12 yuan [1] Revenue Composition - The revenue contribution from enteric-coated hollow capsules and plant-based hollow capsules increased from 26.17% in the same period last year to 35.46% [1]
黄山胶囊:8月22日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-22 09:17
Group 1 - The company Huangshan Capsule announced the convening of its fifth board meeting on August 22, 2025, to review the 2025 semi-annual report and its summary [2] - The meeting was held in a combination of on-site and communication methods [2] - The announcement was reported by the Daily Economic News [2] Group 2 - The company is preparing to disclose its financial performance for the first half of 2025 [2] - The board meeting is a key event for stakeholders to assess the company's financial health and strategic direction [2] - The report will likely include important metrics and insights into the company's operations and market position [2]
黄山胶囊(002817) - 2025年半年度财务报告
2025-08-22 09:16
安徽黄山胶囊股份有限公司 2025 年半年度报告全文 安徽黄山胶囊股份有限公司 2025 年半年度财务报告 【2025 年 8 月】 1 安徽黄山胶囊股份有限公司 2025 年半年度报告全文 第一节 财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为:元 1、合并资产负债表 编制单位:安徽黄山胶囊股份有限公司 2025 年 06 月 30 日 单位:元 | 项目 | 期末余额 | 期初余额 | | --- | --- | --- | | 流动资产: | | | | 货币资金 | 291,927,945.73 | 341,642,031.24 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | | | | 衍生金融资产 | | | | 应收票据 | 266,532.00 | 3,332,429.00 | | 应收账款 | 134,425,432.83 | 110,369,995.29 | | 应收款项融资 | 41,461,881.46 | 28,057,573.29 | | 预付款项 | 167,069.0 ...